most of the volumes come from the vertically challenged playing hacy sac as it is. Actual organic trading is minimal...I see values down to the 1/1000th of a cent in order to provide the appearance of volumes and asks disappear when I place market order bids. Whats next? Can thet trade at 1/10,000 of a cent? GLTA
The increase in short interest seen now also preceeded the prior two study results with OM and Tira. Shorts started to get interested after we did the RS, joined the Russel and prior to ATOMIC. Current interest sits at 5 MM and does not go less than 1 MM, good news is that the OS count is relatively small thanks to the Reverse Split. CYTK is substatially de-risked compared to the last few years IMHO,with a few irons in the fire and cash in the bank. But the SP is back to 2013 levels. There are going to be a few more rodeos...GLTA
They must be trained, given the right messaging & resources, utilize the right physicians, uncover issues, conduct education, understand purchasing protocols, share best practices etc. Usually reps take a year to make an impact, but with a specialised audience and a smaller treatment centre base, it could happen sooner. As an aside,I think that investiagator initiated clinical trials is not the way to go at this early stage of commercialization. It sucks up capital, products are given away free, as companies mistakenly believe that paid physicians study ideas lead to future orders.